Technical Analysis for ENTO - Entero Therapeutics Inc.

Grade Last Price % Change Price Change
C 0.69 7.50% 0.05
ENTO closed up 7.5 percent on Friday, November 1, 2024, on 27 percent of normal volume.
Earnings due: Nov 11
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Narrow Range Bar Range Contraction 7.50%
Wide Bands Range Expansion 7.50%
Up 3 Days in a Row Strength 7.50%
1,2,3 Pullback Bullish Bullish Swing Setup 12.82%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 12.82%
NR7 Range Contraction 12.82%
Narrow Range Bar Range Contraction 12.82%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD, FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Gastrointestinal Disease Gastrointestinal Tract Covid 19

Is ENTO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.5
52 Week Low 0.1873
Average Volume 429,187
200-Day Moving Average 2.44
50-Day Moving Average 0.46
20-Day Moving Average 0.57
10-Day Moving Average 0.63
Average True Range 0.09
RSI (14) 61.39
ADX 40.24
+DI 37.22
-DI 13.98
Chandelier Exit (Long, 3 ATRs) 0.58
Chandelier Exit (Short, 3 ATRs) 0.63
Upper Bollinger Bands 0.78
Lower Bollinger Band 0.37
Percent B (%b) 0.77
BandWidth 72.92
MACD Line 0.06
MACD Signal Line 0.05
MACD Histogram 0.0025
Fundamentals Value
Market Cap 1.07 Million
Num Shares 1.56 Million
EPS 1131.40
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 2.56
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.79
Resistance 3 (R3) 0.79 0.76 0.78
Resistance 2 (R2) 0.76 0.73 0.76 0.77
Resistance 1 (R1) 0.72 0.71 0.74 0.72 0.76
Pivot Point 0.69 0.69 0.69 0.69 0.69
Support 1 (S1) 0.65 0.66 0.67 0.65 0.61
Support 2 (S2) 0.62 0.64 0.62 0.61
Support 3 (S3) 0.58 0.62 0.60
Support 4 (S4) 0.58